Enbrel Etanercept

Enbrel is a prescription biologic drug that has in it the active component etanercept as a recombinant human tumor necrosis factor (TNF) blocker. It is implied in the treatment of various chronic inflammatory autoimmune diseases in which the immune system unintentionally attacks body tissues and causes them to become painful and swollen, and suffer damage to their joints.

Description

Uses

Enbrel is usually used in the treatment of:

  • Rheumatoid Arthritis (RA): To improve or relieve pain, swelling, and worsening joint damage in adults.
  • Psoriatic Arthritis: In support of skin issues and support of joint functionality.
  • Ankylosing Spondylitis: To treat the spinal inflammation and rigidity.
  • Plaque Psoriasis: In adults and children (4 years and older) using moderate or high dose treatment of psoriasis.
  • Juvenile Idiopathic Arthritis (JIA): Applicable to children between the ages of 2 and beyond.

Enbrel controls hyperactive immune responses by interfering with the protein known as TNF, which contributes to the inflammation process.

Administration

  • Enbrel is administered in the form of subcutaneous injection (beneath the skin).
  • It comes in the form of prefilled syringes, autoinjectors, and vials that are to be reconstituted.
  • Self-injection may be performed at home and could be trained as a patient or by a caregiver.
  • The treatment regimen will be based on the condition; however, it is usual to receive it at least once or twice weekly.

Benefits

  • Alleviates pain, swelling, and stiffness.
  • Enhances ease of movement and living conditions.
  • Aids in the prevention of permanent joint damage.
  • Offers skin lesion improvement that is observable in psoriasis patients.

Side Effects & Precautions

Side effects:

Common:

  • Redness, itching, swelling of injection sites
  • Headache, dizziness
  • Breathing illness (cold, sinusitis)

Dangerous risks are:

  • Enhanced vulnerability to infections (tuberculosis, fungal infections, and viral and bacterial infections)
  • Infrequent forms of nervous system ailments, hematologic diseases, or malignancies

Patients with active infections are advised against using Enbrel. Pre-treatment and during treatment, tuberculosis and hepatitis B are encouraged to be monitored and screened regularly.

Conclusion

Enbrel (etanercept) is a well-established biologic therapy that has revolutionized the treatment of autoimmune inflammatory diseases. When appropriately supervised by a physician, it provides substantial symptomatic relief, enhances everyday functioning, slows the rate of disease pathogenesis, and is therefore a crucial choice for numerous chronic illness sufferers with immunity-related diseases.

Reviews

There are no reviews yet.

Be the first to review “Enbrel Etanercept”

Your email address will not be published. Required fields are marked *